We are pleased to inform you that the first trial participant was enrolled at the Isala Klinieken in Zwolle (NL) on 29th of November 2022. Thank you for your great effort!
We are pleased to inform that the Albert Schweitzer Ziekenhuis (ASZ) in Dordrecht has enrolled the first study participant on 9th of August 2022. Until today the ASZ enrolled 3 study participants. Thank you for your great effort!
https://www.safesspe.ch/wp-content/uploads/sites/5/2020/05/safesspe-logo-400x82px-300x62.png00mpelusohttps://www.safesspe.ch/wp-content/uploads/sites/5/2020/05/safesspe-logo-400x82px-300x62.pngmpeluso2022-10-13 09:04:282022-10-13 09:04:28The Albert Schweitzer Ziekenhuis (ASZ) in Dordrecht has enrolled the first study participant
We are happy to inform you that the fourth Dutch site, the Isala Klinieken in Zwolle, could be opened for patient recruitment. We wish the study team good luck!
https://www.safesspe.ch/wp-content/uploads/sites/5/2020/05/safesspe-logo-400x82px-300x62.png00mpelusohttps://www.safesspe.ch/wp-content/uploads/sites/5/2020/05/safesspe-logo-400x82px-300x62.pngmpeluso2022-05-23 12:29:482022-06-09 12:32:29A new site in the Netherlands, the Isala Klinieken in Zwolle, was initiated and started with patient recruiting.
First patient enrolled in Zwolle!
We are pleased to inform you that the first trial participant was enrolled at the Isala Klinieken in Zwolle (NL) on 29th of November 2022. Thank you for your great effort!
The Albert Schweitzer Ziekenhuis (ASZ) in Dordrecht has enrolled the first study participant
We are pleased to inform that the Albert Schweitzer Ziekenhuis (ASZ) in Dordrecht has enrolled the first study participant on 9th of August 2022. Until today the ASZ enrolled 3 study participants. Thank you for your great effort!
A new site in the Netherlands, the Isala Klinieken in Zwolle, was initiated and started with patient recruiting.
We are happy to inform you that the fourth Dutch site, the Isala Klinieken in Zwolle, could be opened for patient recruitment. We wish the study team good luck!